Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Toth, M; Gresack, J E; Bangasser, D A; Plona, Z; Valentino, R J; Flandreau, E I; Mansuy, I M; Merlo-Pich, E; Geyer, M A; Risbrough, V B (2014). Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology, 39:1409-1419.

Devor, A; Bandettini, P A; Boas, D A; Bower, J M; Buxton, R B; Cohen, L B; Dale, A M; Einevoll, G T; Fox, P T; Franceschini, M A; Friston, K J; Fujimoto, J G; Geyer, M A; Greenberg, J H; Halgren, E; Hämäläinen, M S; Helmchen, F; Hyman, B T; Jasanoff, A; Jernigan, T L; Judd, L L; Kim, S G; Kleinfeld, D; Kopell, N J; Kutas, M; Kwong, K K; Larkum, M E; Lo, E H; Magistretti, P J; Mandeville, J B; Masliah, E; Mitra, P P; Mobley, W C; Moskowitz, M A; Nimmerjahn, A; Reynolds, J H; Rosen, B R; Salzberg, B M; Schaffer, C B; Silva, G A; So, P T C; Spitzer, N C; Tootell, R B; Van Essen, D C; Vanduffel, W; Vinogradov, S A; Wald, L L; Wang, L V; Weber, B; Yodh, A G (2013). The challenge of connecting the dots in the B.R.A.I.N. Neuron, 80(2):270-274.

Quednow, Boris B; Kometer, M; Geyer, M A; Vollenweider, F X (2012). Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology, 37(3):630-640.

Hilti, C C; Delko, T; Orosz, A T; Thomann, K; Ludewig, S; Geyer, M A; Vollenweider, F X; Feldon, J; Cattapan-Ludewig, K (2010). Sustained attention and planning deficits but intact attentional set-shifting in neuroleptic-naïve first-episode schizophrenia patients. Neuropsychobiology, 61(2):79-86.

Quednow, Boris B; Geyer, M A; Halberstadt, A L (2009). Serotonin and Schizophrenia. In: Müller, C R; Jacobs, B. Handbook of the Behavioral Neurobiology of Serotonin. London: Academic Press, 585-620.

Geyer, M A; Vollenweider, F X (2008). Serotonin research: contributions to understanding psychoses. Trends in Pharmacological Sciences, 29(9):445-453.

Csomor, P A; Stadler, R R; Feldon, J; Yee, B K; Geyer, M A; Vollenweider, F X (2008). Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology, 33(3):497-512.

This list was generated on Sun Oct 22 03:59:51 2017 CEST.